HHT
Clinical trials for HHT explained in plain language.
Never miss a new study
Get alerted when new HHT trials appear
Sign up with your email to follow new studies for HHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a daily pill stop HHT nosebleeds? new trial investigates.
Disease control OngoingThis study tests whether a low dose of the drug pazopanib, taken daily for 24 weeks, can reduce the severity and duration of nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). About 70 participants will receive either the active drug or a placebo. The research…
Matched conditions: HHT
Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
HHT patients wanted for landmark registry study
Knowledge-focused OngoingThis study is creating a registry of up to 1,000 adults with Hereditary Hemorrhagic Telangiectasia (HHT) from four North American centers. Researchers will collect health information over time to learn how the disease changes and what factors affect those changes. The goal is to …
Matched conditions: HHT
Sponsor: Unity Health Toronto • Aim: Knowledge-focused
Last updated May 17, 2026 03:56 UTC